The Practical Implications of Association of Molecular Pathology v. Myriad Genetics, Inc. and BRCA1 - & BRCA2 - Based Hereditary Cancer Test Patent Litig. v. Ambry Genetics Corp. on the Biotechnology Industry

Authors

Samuel J. Berse

Recommended Citation

Berse, Samuel J. (2015) "The Practical Implications of Association of Molecular Pathology v. Myriad Genetics, Inc. and BRCA1 - & BRCA2 - Based Hereditary Cancer Test Patent Litig. v. Ambry Genetics Corp. on the Biotechnology Industry," Seton Hall Journal of Legislation and Public Policy: Vol. 39: Iss. 2, Article 7.
Available at: https://scholarship.shu.edu/shlj/vol39/iss2/7